Observational studyBMC infectious diseases2025
Prognostic factors for mortality and respiratory failure in hospitalized patients with COVID-19 after three-dose vaccination: a retrospective cohort study during the Omicron period.
Observational study in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundDespite high vaccination rates, severe and critical illnesses in hospitalized patients with COVID-19 continue to pose significant challenges to healthcare systems. This study aimed to identify factors associated with mortality among hospitalized patients with COVID-19 who had received three vaccine doses during the spread of the SARS-CoV-2 Omicron variant.
methodsThis retrospective observational study was conducted at the Taipei Veterans General Hospital between April and June 2022. Hospitalized adult patients with confirmed COVID-19 who had received three vaccine doses before diagnosis were included. Demographic data, comorbidities, disease severity indicators, laboratory values, and treatment details were collected from the electronic records. Logistic regression analysis was used to identify the factors associated with 28-day mortality and the need for invasive mechanical ventilation.
resultsA total of 620 patients with a median age of 75 years were hospitalized for COVID-19, and the 28-day mortality rate was 7.9%. The independent predictors of mortality included a higher comorbidity burden, elevated World Health Organization (WHO) ordinal scale scores, elevated neutrophil-to-lymphocyte ratios (NLR), and thrombocytopenia. Among the 610 initially non-ventilated patients, 6.6% required invasive mechanical ventilation. Hematological malignancy, metastatic cancer, higher WHO ordinal scales, elevated NLR and bacterial secondary infection were significant risk factors for respiratory failure.
conclusionDespite receiving three doses of the COVID-19 vaccines, patients hospitalized with COVID-19 continue to experience notable rates of mortality and respiratory failure. During the current endemic phase of COVID-19, these prognostic indicators can help guide the management and early intervention of high-risk patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.